<p><strong>可持续发展报告提供了 2023 年至 2025 年公司在环境、社会和治理方面的举措数据</strong></p>
<p>加利福尼亚州门洛帕克，2026 年 4 月 22 日（全球新闻稿）——Sight Sciences, Inc.（纳斯达克：SGHT），一家专注于开发和商业化创新性干预技术以提升护理标准的眼科技术公司，今天宣布已发布其年度可持续发展报告，重点介绍公司在过去三年中的可持续发展活动、表现和成果。</p>
<p>“我们很自豪地发布我们的第三份可持续发展报告，反映了我们在透明度、运营纪律和环境影响减少方面的持续进展，同时重申我们为所有利益相关者创造长期价值的承诺，” Sight Sciences 的联合创始人兼首席执行官 Paul Badawi 表示。“我们将继续专注于开发变革性的干预技术，使眼科提供者能够在程序上提升护理标准——赋予人们持续视力的能力，同时保持强有力的环境、社会和公司治理实践。”</p>
<p><strong>可持续发展报告包括：</strong></p>
<p><strong>环境举措：</strong> 详细介绍了 Sight Sciences 通过提高能源效率、减少废物和可持续实践来降低其环境足迹的努力，并包括排放报告。</p>
<p><strong>社会责任：</strong> 介绍了 Sight Sciences 支持社区参与、多样性、公平和包容性以及员工福祉的举措，包括薪酬公平、员工档案、健康和安全措施、职业发展和学习、员工培训以及自愿员工流失率。</p>
<p><strong>治理实践：</strong> 披露了 Sight Sciences 的治理框架、合规程序、伦理标准、信息安全和数据隐私控制，包括对网络安全和负责任的人工智能使用的监督，以及对透明度和问责制的承诺。</p>
<p><strong>可持续发展报告的主要亮点：</strong></p>
<ul>
<li>从 2023 年至 2025 年，Sight Sciences 已向 24 个国家的 24 个不同项目捐款，以支持贫困护理。</li>
<li>我们报告了 2025 年范围 1 至范围 3 排放量减少超过 20%。我们承诺将来报告我们的排放量，并遵守所有适用的法律法规，以帮助减少温室气体并鼓励低温室气体排放技术的市场采用。</li>
<li>截至 2025 年 12 月 31 日，我们在全球雇佣了 187 名员工，其中 56% 的员工为女性。</li>
</ul>
<p>有关更多信息和亮点，请参阅完整的可持续发展报告，报告可在此处找到。所有环境、社会和治理（ESG）实践均由公司的提名和公司治理委员会监督。</p>
<p><strong>关于 Sight Sciences</strong></p>
<p>Sight Sciences 是一家专注于开发和商业化创新和干预解决方案的眼科技术公司，旨在转变护理并改善患者生活。通过微创或非侵入性的方法，针对全球最常见眼病的根本原因，Sight Sciences 致力于创造更有效的治疗范式，以增强患者护理并取代传统过时的方法。公司的 OMNI®外科系统和 OMNI® Edge 外科系统是无植入物的微创青光眼手术技术，适用于美国的成年原发性开角型青光眼患者，以降低眼内压。OMNI 外科系统已获得 CE 标记，用于施行 Schlemm 管的导管化和经腔内粘弹扩张，以及切割小梁网以降低成年开角型青光眼患者的眼内压。青光眼是导致不可逆失明的全球主要原因。SION®外科系统是一种无刀、手动操作的设备，用于眼科手术中切除小梁网。公司的 TearCare®系统在美国获得 510(k) 批准，用于对因睑板腺疾病（MGD）导致的蒸发性干眼症的成年患者进行局部热疗，帮助医生清除腺体阻塞，以解决干眼症的主要原因。有关更多信息，请访问 www.sightsciences.com。</p>
<p>Sight Sciences 和 TearCare 是 Sight Sciences 在美国注册的商标。OMNI、SION、SmartLids 和 Sight Sciences 标志是 Sight Sciences 在美国、欧盟和其他地区注册的商标。</p>
<p>© 2026 Sight Sciences。保留所有权利。</p>
<p><strong>媒体联系：</strong></p>
<p>pr@SightSciences.com</p>
<p><strong>投资者联系：</strong></p>
<p>Philip Taylor</p>
<p>Gilmartin Group</p>
<p>415.937.5406</p>
<p>Investor.Relations@Sightsciences.com</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZNU5USXhNaU0zTlRVd05qQXhJekl5TURrM056RT0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZNU5USXhNaU0zTlRVd05qQXhJekl5TURrM056RT0"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MTYwMTgxMDgtZWJiNi00OWI1LTk2NWItNzgxNzUwZDNjODc5LTEyMjEzMjQtMjAyNi0wNC0yMi1lbg==/tiny/Sight-Sciences-Inc-.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MTYwMTgxMDgtZWJiNi00OWI1LTk2NWItNzgxNzUwZDNjODc5LTEyMjEzMjQtMjAyNi0wNC0yMi1lbg==/tiny/Sight-Sciences-Inc-.png"/></p>

SGHT

美国医药设备 ETF - iShares

标普健康医疗设备 ETF - SPDR

<p>Sight Sciences, Inc.（纳斯达克代码：SGHT）发布了其年度可持续发展报告，详细介绍了其 2023 年至 2025 年的环境、社会和治理（ESG）举措。报告强调了超过 20% 的排放减少以及公司对透明度和问责制的承诺。主要举措包括社区支持、多样性和员工福祉。截至 2025 年 12 月 31 日，56% 的员工为女性。报告强调了 Sight Sciences 通过创新技术提升眼保健的使命，同时保持强有力的 ESG 实践</p>

<p><strong>The Sustainability Report provides data for 2023 through 2025 on the Company’s environmental, social, and governance initiatives</strong></p>
<div class="lb-trans"><p><strong>可持续发展报告提供了 2023 年至 2025 年公司在环境、社会和治理方面的举措数据</strong></p>
</div><p>MENLO PARK, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, announced today that it has published its annual Sustainability Report, highlighting the Company’s sustainability activities, performance and results from the last three years.</p>
<div class="lb-trans"><p>加利福尼亚州门洛帕克，2026 年 4 月 22 日（全球新闻稿）——Sight Sciences, Inc.（纳斯达克：SGHT），一家专注于开发和商业化创新性干预技术以提升护理标准的眼科技术公司，今天宣布已发布其年度可持续发展报告，重点介绍公司在过去三年中的可持续发展活动、表现和成果。</p>
</div><p>“We are proud to issue our third Sustainability Report, reflecting our continued progress in transparency, operational discipline, and environmental impact reduction, while reinforcing our commitment to creating long term value for all stakeholders,” stated Paul Badawi, co-founder and Chief Executive Officer of Sight Sciences. “We remain focused on our mission to develop transformative, interventional technologies that allow eyecare providers to procedurally elevate the standards of care—empowering people to keep seeing, while also maintaining strong environmental, social and corporate governance practices.”</p>
<div class="lb-trans"><p>“我们很自豪地发布我们的第三份可持续发展报告，反映了我们在透明度、运营纪律和环境影响减少方面的持续进展，同时重申我们为所有利益相关者创造长期价值的承诺，” Sight Sciences 的联合创始人兼首席执行官 Paul Badawi 表示。“我们将继续专注于开发变革性的干预技术，使眼科提供者能够在程序上提升护理标准——赋予人们持续视力的能力，同时保持强有力的环境、社会和公司治理实践。”</p>
</div><p><strong>The Sustainability Report includes:</strong></p>
<div class="lb-trans"><p><strong>可持续发展报告包括：</strong></p>
</div><p><strong>Environmental Initiatives:</strong> Details of Sight Sciences’ efforts to reduce its environmental footprint through energy efficiency, waste reduction, and sustainable practices, and includes emissions reporting.</p>
<div class="lb-trans"><p><strong>环境举措：</strong> 详细介绍了 Sight Sciences 通过提高能源效率、减少废物和可持续实践来降低其环境足迹的努力，并包括排放报告。</p>
</div><p><strong>Social Responsibility:</strong> Insights into Sight Sciences’ initiatives to support community engagement, diversity, equity, and inclusion, and employee well-being, including pay equity and employee profiles, health and safety measures, career development and learning, employee training and voluntary employee turnover.</p>
<div class="lb-trans"><p><strong>社会责任：</strong> 介绍了 Sight Sciences 支持社区参与、多样性、公平和包容性以及员工福祉的举措，包括薪酬公平、员工档案、健康和安全措施、职业发展和学习、员工培训以及自愿员工流失率。</p>
</div><p><strong>Governance Practices:</strong> Disclosure of Sight Sciences’ governance framework, compliance programs, ethical standards, information security &amp; data privacy controls, including oversight of cybersecurity and responsible artificial intelligence use and commitment to transparency and accountability.</p>
<div class="lb-trans"><p><strong>治理实践：</strong> 披露了 Sight Sciences 的治理框架、合规程序、伦理标准、信息安全和数据隐私控制，包括对网络安全和负责任的人工智能使用的监督，以及对透明度和问责制的承诺。</p>
</div><p><strong>Key Highlights from the Sustainability Report:</strong></p>
<div class="lb-trans"><p><strong>可持续发展报告的主要亮点：</strong></p>
</div><ul>
<li>Sight Sciences has donated to 24 different programs to support indigent care in 24 countries from 2023 through 2025.</li>
<li>We reported a &gt;20% reduction in emissions in Scope 1 through Scope 3 emissions in 2025. We commit to reporting our emissions in the future and complying with all applicable laws and regulations that help reduce GHG and encourage market adoption of low GHG emission technologies.</li>
<li>As of December 31, 2025, we employed 187 people worldwide, with 56% of our workforce comprised of women.</li>
</ul>
<div class="lb-trans"><ul>
<li>从 2023 年至 2025 年，Sight Sciences 已向 24 个国家的 24 个不同项目捐款，以支持贫困护理。</li>
<li>我们报告了 2025 年范围 1 至范围 3 排放量减少超过 20%。我们承诺将来报告我们的排放量，并遵守所有适用的法律法规，以帮助减少温室气体并鼓励低温室气体排放技术的市场采用。</li>
<li>截至 2025 年 12 月 31 日，我们在全球雇佣了 187 名员工，其中 56% 的员工为女性。</li>
</ul>
</div><p>For additional information and highlights, please see the full Sustainability Report, which can be found here. All Environmental, Social, and Governance (ESG) practices are overseen by the Company’s Nominating and Corporate Governance committee.</p>
<div class="lb-trans"><p>有关更多信息和亮点，请参阅完整的可持续发展报告，报告可在此处找到。所有环境、社会和治理（ESG）实践均由公司的提名和公司治理委员会监督。</p>
</div><p><strong>About Sight Sciences</strong></p>
<div class="lb-trans"><p><strong>关于 Sight Sciences</strong></p>
</div><p>Sight Sciences is an eyecare technology company focused on developing and commercializing innovative and interventional solutions intended to transform care and improve patients’ lives. Using minimally invasive or non-invasive approaches to target the underlying causes of the world’s most prevalent eye diseases, Sight Sciences seeks to create more effective treatment paradigms that enhance patient care and supplant conventional outdated approaches. The Company’s OMNI® Surgical System and OMNI® Edge Surgical System are implant-free, minimally invasive glaucoma surgery technologies indicated in the United States to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The OMNI Surgical System is CE Marked for the catheterization and transluminal viscodilation of Schlemm’s canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma. Glaucoma is the world’s leading cause of irreversible blindness. The SION® Surgical System is a bladeless, manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The Company’s TearCare® System is 510(k) cleared in the United States for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the leading cause of dry eye disease. Visit www.sightsciences.com for more information.</p>
<div class="lb-trans"><p>Sight Sciences 是一家专注于开发和商业化创新和干预解决方案的眼科技术公司，旨在转变护理并改善患者生活。通过微创或非侵入性的方法，针对全球最常见眼病的根本原因，Sight Sciences 致力于创造更有效的治疗范式，以增强患者护理并取代传统过时的方法。公司的 OMNI®外科系统和 OMNI® Edge 外科系统是无植入物的微创青光眼手术技术，适用于美国的成年原发性开角型青光眼患者，以降低眼内压。OMNI 外科系统已获得 CE 标记，用于施行 Schlemm 管的导管化和经腔内粘弹扩张，以及切割小梁网以降低成年开角型青光眼患者的眼内压。青光眼是导致不可逆失明的全球主要原因。SION®外科系统是一种无刀、手动操作的设备，用于眼科手术中切除小梁网。公司的 TearCare®系统在美国获得 510(k) 批准，用于对因睑板腺疾病（MGD）导致的蒸发性干眼症的成年患者进行局部热疗，帮助医生清除腺体阻塞，以解决干眼症的主要原因。有关更多信息，请访问 www.sightsciences.com。</p>
</div><p>Sight Sciences and TearCare are trademarks of Sight Sciences registered in the United States. OMNI, SION, SmartLids, and the Sight Sciences logo are trademarks of Sight Sciences registered in the United States, European Union and other territories.</p>
<div class="lb-trans"><p>Sight Sciences 和 TearCare 是 Sight Sciences 在美国注册的商标。OMNI、SION、SmartLids 和 Sight Sciences 标志是 Sight Sciences 在美国、欧盟和其他地区注册的商标。</p>
</div><p>© 2026 Sight Sciences. All rights reserved.</p>
<div class="lb-trans"><p>© 2026 Sight Sciences。保留所有权利。</p>
</div><p><strong>Media contact:</strong></p>
<div class="lb-trans"><p><strong>媒体联系：</strong></p>
</div><p>pr@SightSciences.com</p>
<div class="lb-trans"><p>pr@SightSciences.com</p>
</div><p><strong>Investor contact:</strong></p>
<div class="lb-trans"><p><strong>投资者联系：</strong></p>
</div><p>Philip Taylor</p>
<div class="lb-trans"><p>Philip Taylor</p>
</div><p>Gilmartin Group</p>
<div class="lb-trans"><p>Gilmartin Group</p>
</div><p>415.937.5406</p>
<div class="lb-trans"><p>415.937.5406</p>
</div><p>Investor.Relations@Sightsciences.com</p>
<div class="lb-trans"><p>Investor.Relations@Sightsciences.com</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZNU5USXhNaU0zTlRVd05qQXhJekl5TURrM056RT0" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTY5NTIxMiM3NTUwNjAxIzIyMDk3NzE="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MTYwMTgxMDgtZWJiNi00OWI1LTk2NWItNzgxNzUwZDNjODc5LTEyMjEzMjQtMjAyNi0wNC0yMi1lbg==/tiny/Sight-Sciences-Inc-.png" alt="" original-src="https://ml.globenewswire.com/media/MTYwMTgxMDgtZWJiNi00OWI1LTk2NWItNzgxNzUwZDNjODc5LTEyMjEzMjQtMjAyNi0wNC0yMi1lbg==/tiny/Sight-Sciences-Inc-.png"/></p>

Sight Sciences 宣布发布其可持续发展报告 | SGHT 股票新闻